NASDAQ:ERYP

ERYTECH Pharma News Headlines

$7.03
0.00 (0.00 %)
(As of 05/10/2021 12:00 AM ET)
Add
Compare
Today's Range
$7.03
$7.03
50-Day Range
$6.74
$7.56
52-Week Range
$5.00
$13.95
Volume285 shs
Average Volume20,492 shs
Market Capitalization$151.99 million
P/E RatioN/A
Dividend YieldN/A
Beta2.73

Headlines

ERYTECH Pharma (NASDAQ ERYP) News Headlines Today

SourceHeadline
ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q1 2021 Results - Earnings Call TranscriptERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 12:55 PM
Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2021Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2021
finance.yahoo.com - May 7 at 3:18 PM
ERYTECH Provides Business Update and  Reports Financial Results for the First Quarter of 2021ERYTECH Provides Business Update and Reports Financial Results for the First Quarter of 2021
finance.yahoo.com - May 4 at 6:39 PM
ERYTECH Pharma S.A. (NASDAQ:ERYP) Expected to Announce Earnings of -$0.89 Per ShareERYTECH Pharma S.A. (NASDAQ:ERYP) Expected to Announce Earnings of -$0.89 Per Share
americanbankingnews.com - May 2 at 12:38 PM
ERYTECH Pharma (ERYP) Set to Announce Earnings on TuesdayERYTECH Pharma (ERYP) Set to Announce Earnings on Tuesday
americanbankingnews.com - April 29 at 8:52 AM
ERYTECH Pharma S.A. (NASDAQ:ERYP) Short Interest UpdateERYTECH Pharma S.A. (NASDAQ:ERYP) Short Interest Update
americanbankingnews.com - April 29 at 7:48 AM
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharmas EpidiolexThe Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex
markets.businessinsider.com - April 20 at 8:31 AM
ERYTECH Requested a Pre-BLA Meeting with the FDA to Discuss Path to Approval in ALLERYTECH Requested a Pre-BLA Meeting with the FDA to Discuss Path to Approval in ALL
finance.yahoo.com - April 20 at 8:31 AM
ERYTECH Announces Completion of First Cohort in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic CancerERYTECH Announces Completion of First Cohort in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer
finance.yahoo.com - April 19 at 9:43 AM
ERYTECH to Participate in Upcoming Virtual Investor Conferences in AprilERYTECH to Participate in Upcoming Virtual Investor Conferences in April
finance.yahoo.com - April 7 at 5:59 PM
Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2021Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2021
finance.yahoo.com - April 7 at 12:58 PM
ERYTECH Pharma S.A. (ERYP.PA)ERYTECH Pharma S.A. (ERYP.PA)
au.finance.yahoo.com - March 18 at 8:39 AM
Erytech Pharma S.A.: ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020Erytech Pharma S.A.: ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020
bloomberg.com - March 10 at 6:30 PM
ERYTECH Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-FERYTECH Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F
finance.yahoo.com - March 9 at 5:07 PM
Monthly information related to total number of voting rights and shares composing the share capital – February 28, 2021Monthly information related to total number of voting rights and shares composing the share capital – February 28, 2021
finance.yahoo.com - March 5 at 1:43 PM
ERYTECH Pharma (ERYP) Sees Hammer Chart Pattern: Time to Buy?ERYTECH Pharma (ERYP) Sees Hammer Chart Pattern: Time to Buy?
finance.yahoo.com - March 5 at 8:43 AM
ERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and Business UpdateERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and Business Update
finance.yahoo.com - March 4 at 8:33 PM
Erytech Pharma S.A.: ERYTECH to Participate in Upcoming Virtual Investor Conferences in MarchErytech Pharma S.A.: ERYTECH to Participate in Upcoming Virtual Investor Conferences in March
bloomberg.com - February 26 at 9:29 AM
ERYTECH to Participate in Upcoming Virtual Investor Conferences in MarchERYTECH to Participate in Upcoming Virtual Investor Conferences in March
finance.yahoo.com - February 24 at 8:14 PM
ERYTECH to Present at the 2021 BIO CEO & Investor ConferenceERYTECH to Present at the 2021 BIO CEO & Investor Conference
finance.yahoo.com - February 10 at 8:26 PM
Erytech Pharma S.A.: ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final AnalysisErytech Pharma S.A.: ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis
bloomberg.com - February 9 at 10:42 PM
ERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final AnalysisERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis
benzinga.com - February 8 at 5:04 AM
ERYTECH Announces TRYbeCA-1 Phase 3 Trial  in 2L Pancreatic Cancer to Continue to Final AnalysisERYTECH Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to Final Analysis
finance.yahoo.com - February 8 at 5:04 AM
Erytech Pharma S.A.: Monthly information related to total number of voting rights and shares composing the share capitalErytech Pharma S.A.: Monthly information related to total number of voting rights and shares composing the share capital
bloomberg.com - February 6 at 8:14 PM
ERYTECH Highlights 2021 Milestones and Provides Update on Cash PositionERYTECH Highlights 2021 Milestones and Provides Update on Cash Position
finance.yahoo.com - January 25 at 5:46 PM
ERYTECH Announces First Patient Enrolled in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic CancerERYTECH Announces First Patient Enrolled in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer
finance.yahoo.com - January 14 at 7:34 PM
ERYTECH to Present at the H.C. Wainwright Virtual BioConnect 2021 ConferenceERYTECH to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
finance.yahoo.com - January 6 at 8:00 PM
Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2020Monthly information related to total number of voting rights and shares composing the share capital – December 31, 2020
finance.yahoo.com - January 6 at 2:58 PM
ERYTECH to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access EventERYTECH to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event
finance.yahoo.com - January 4 at 8:35 AM
Erytech Pharma S.A.: ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic CancerErytech Pharma S.A.: ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer
finanznachrichten.de - December 16 at 7:33 AM
ERYTECH Completes Enrollment in TRYbeCA-1  Phase 3 Trial in Second-Line Pancreatic CancerERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer
finance.yahoo.com - December 14 at 7:17 PM
Erytech Pharma S.A.: ERYTECH to Present at the JMP Securities Hematology SummitErytech Pharma S.A.: ERYTECH to Present at the JMP Securities Hematology Summit
finanznachrichten.de - December 12 at 7:40 PM
ERYTECH to Present at the JMP Securities Hematology SummitERYTECH to Present at the JMP Securities Hematology Summit
finance.yahoo.com - December 10 at 5:33 PM
Monthly information related to total number of voting rights and shares composing the share capital – November 30, 2020Monthly information related to total number of voting rights and shares composing the share capital – November 30, 2020
finance.yahoo.com - December 10 at 12:33 PM
ERYTECH Announces Positive Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Presented at the American Society of Hematology Annual MeetingERYTECH Announces Positive Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Presented at the American Society of Hematology Annual Meeting
finance.yahoo.com - December 7 at 2:43 AM
ERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual MeetingERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual Meeting
finance.yahoo.com - December 3 at 6:05 PM
Erytech Pharma S.A.: ERYTECH to Present at Jefferies Virtual Healthcare ConferenceErytech Pharma S.A.: ERYTECH to Present at Jefferies Virtual Healthcare Conference
finanznachrichten.de - November 12 at 7:48 PM
ERYTECH to Present at Jefferies Virtual Healthcare ConferenceERYTECH to Present at Jefferies Virtual Healthcare Conference
finance.yahoo.com - November 12 at 7:48 PM
ERYTECH Pharmas (ERYP) CEO Gil Beyen on Q3 2020 Results - Earnings Call TranscriptERYTECH Pharma's (ERYP) CEO Gil Beyen on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 8 at 6:38 PM
ERYTECH Announces Abstract with Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Selected for Oral Presentation at the American Society of Hematology 2020 Annual MeetingERYTECH Announces Abstract with Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Selected for Oral Presentation at the American Society of Hematology 2020 Annual Meeting
finance.yahoo.com - November 5 at 9:38 AM
Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2020.Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2020.
finance.yahoo.com - November 4 at 1:24 PM
Erytech Pharma S.A.: ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French GovernmentErytech Pharma S.A.: ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French Government
finanznachrichten.de - November 2 at 6:42 AM
ERYTECH secures €10M in non-dilutive financingERYTECH secures €10M in non-dilutive financing
seekingalpha.com - November 2 at 6:42 AM
Erytech Pharma S.A.: ERYTECH Appoints Stewart Craig as Chief Technical OfficerErytech Pharma S.A.: ERYTECH Appoints Stewart Craig as Chief Technical Officer
finanznachrichten.de - October 26 at 6:13 PM
ERYTECH Appoints Stewart Craig as Chief Technical OfficerERYTECH Appoints Stewart Craig as Chief Technical Officer
finance.yahoo.com - October 26 at 6:13 PM
ERYTECH: Trials In Pancreatic CancerERYTECH: Trials In Pancreatic Cancer
seekingalpha.com - October 23 at 9:52 AM
Monthly information related to total number of voting rights and shares composing the share capital - September 30, 2020Monthly information related to total number of voting rights and shares composing the share capital - September 30, 2020
finance.yahoo.com - October 22 at 11:23 PM
ERYTECH Pharma S.A. (2E4A.F)ERYTECH Pharma S.A. (2E4A.F)
in.finance.yahoo.com - October 9 at 5:54 PM
ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q2 2020 Results - Earnings Call TranscriptERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - September 22 at 4:00 PM
Erytech inks $30M stock sales deal with CowenErytech inks $30M stock sales deal with Cowen
seekingalpha.com - September 22 at 4:43 AM
This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.